Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Suisse (CSUI) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Cannabis Suisse (CSUI) over the last 10 years, with Q4 2025 value amounting to $510025.0.

  • Cannabis Suisse's Liabilities and Shareholders Equity fell 3216.37% to $510025.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $2.4 million, marking a year-over-year decrease of 2000.17%. This contributed to the annual value of $635075.0 for FY2025, which is 2917.03% down from last year.
  • Latest data reveals that Cannabis Suisse reported Liabilities and Shareholders Equity of $510025.0 as of Q4 2025, which was down 3216.37% from $570344.0 recorded in Q3 2025.
  • Over the past 5 years, Cannabis Suisse's Liabilities and Shareholders Equity peaked at $896623.0 during Q2 2024, and registered a low of $5985.0 during Q3 2021.
  • Its 5-year average for Liabilities and Shareholders Equity is $365299.3, with a median of $346303.0 in 2023.
  • Per our database at Business Quant, Cannabis Suisse's Liabilities and Shareholders Equity crashed by 9828.77% in 2021 and then surged by 270690.83% in 2023.
  • Over the past 5 years, Cannabis Suisse's Liabilities and Shareholders Equity (Quarter) stood at $16952.0 in 2021, then skyrocketed by 308.9% to $69317.0 in 2022, then skyrocketed by 325.74% to $295110.0 in 2023, then skyrocketed by 154.77% to $751847.0 in 2024, then plummeted by 32.16% to $510025.0 in 2025.
  • Its Liabilities and Shareholders Equity stands at $510025.0 for Q4 2025, versus $570344.0 for Q3 2025 and $635075.0 for Q2 2025.